Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Companion Diagnostic Tests in Oncology market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Companion Diagnostic Tests in Oncology market. Detailed analysis of key players, along with key growth strategies adopted by Companion Diagnostic Tests in Oncology industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Siemens Healthcare
BioMerieux
Genomic Health
Abbott
Thermo Fisher
Illumina
Agilent
QIAGEN
Roche
Agendia
By Type:
Protein Detection
DNA Detection
By End-User:
Pharmaceutical & Biotechnology Companies
Medical Device Companies
Research Institutes
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Companion Diagnostic Tests in Oncology Market
-
1.3 Market Segment by Type
-
1.3.1 USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Protein Detection from 2016 to 2027
-
1.3.2 USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of DNA Detection from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2016 to 2027
-
1.4.2 USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Medical Device Companies from 2016 to 2027
-
1.4.3 USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Research Institutes from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Companion Diagnostic Tests in Oncology Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Companion Diagnostic Tests in Oncology by Major Types
-
3.4.1 Market Size and Growth Rate of Protein Detection
-
3.4.2 Market Size and Growth Rate of DNA Detection
4 Segmentation of Companion Diagnostic Tests in Oncology Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Companion Diagnostic Tests in Oncology by Major End-Users
-
4.4.1 Market Size and Growth Rate of Companion Diagnostic Tests in Oncology in Pharmaceutical & Biotechnology Companies
-
4.4.2 Market Size and Growth Rate of Companion Diagnostic Tests in Oncology in Medical Device Companies
-
4.4.3 Market Size and Growth Rate of Companion Diagnostic Tests in Oncology in Research Institutes
5 Market Analysis by Regions
-
5.1 USA Companion Diagnostic Tests in Oncology Production Analysis by Regions
-
5.2 USA Companion Diagnostic Tests in Oncology Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Companion Diagnostic Tests in Oncology Landscape Analysis
-
6.1 West USA Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types
-
6.2 West USA Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users
7 South USA Companion Diagnostic Tests in Oncology Landscape Analysis
-
7.1 South USA Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types
-
7.2 South USA Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users
8 Middle West USA Companion Diagnostic Tests in Oncology Landscape Analysis
-
8.1 Middle West USA Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types
-
8.2 Middle West USA Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users
9 Northeast USA Companion Diagnostic Tests in Oncology Landscape Analysis
-
9.1 Northeast USA Companion Diagnostic Tests in Oncology Landscape Analysis by Major Types
-
9.2 Northeast USA Companion Diagnostic Tests in Oncology Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Siemens Healthcare
-
10.1.1 Siemens Healthcare Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 BioMerieux
-
10.2.1 BioMerieux Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Genomic Health
-
10.3.1 Genomic Health Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Abbott
-
10.4.1 Abbott Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Thermo Fisher
-
10.5.1 Thermo Fisher Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Illumina
-
10.6.1 Illumina Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Agilent
-
10.7.1 Agilent Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 QIAGEN
-
10.8.1 QIAGEN Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Roche
-
10.9.1 Roche Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Agendia
-
10.10.1 Agendia Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Protein Detection from 2016 to 2027
-
Figure USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of DNA Detection from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies from 2016 to 2027
-
Figure USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Medical Device Companies from 2016 to 2027
-
Figure USA Companion Diagnostic Tests in Oncology Market Size and Growth Rate of Research Institutes from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Companion Diagnostic Tests in Oncology Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Companion Diagnostic Tests in Oncology Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Companion Diagnostic Tests in Oncology
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Companion Diagnostic Tests in Oncology by Different Types from 2016 to 2027
-
Table Consumption Share of Companion Diagnostic Tests in Oncology by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Protein Detection
-
Figure Market Size and Growth Rate of DNA Detection
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Companion Diagnostic Tests in Oncology by Different End-Users from 2016 to 2027
-
Table Consumption Share of Companion Diagnostic Tests in Oncology by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies
-
Figure Market Size and Growth Rate of Medical Device Companies
-
Figure Market Size and Growth Rate of Research Institutes
-
Table USA Companion Diagnostic Tests in Oncology Production by Regions
-
Table USA Companion Diagnostic Tests in Oncology Production Share by Regions
-
Figure USA Companion Diagnostic Tests in Oncology Production Share by Regions in 2016
-
Figure USA Companion Diagnostic Tests in Oncology Production Share by Regions in 2021
-
Figure USA Companion Diagnostic Tests in Oncology Production Share by Regions in 2027
-
Table USA Companion Diagnostic Tests in Oncology Consumption by Regions
-
Table USA Companion Diagnostic Tests in Oncology Consumption Share by Regions
-
Figure USA Companion Diagnostic Tests in Oncology Consumption Share by Regions in 2016
-
Figure USA Companion Diagnostic Tests in Oncology Consumption Share by Regions in 2021
-
Figure USA Companion Diagnostic Tests in Oncology Consumption Share by Regions in 2027
-
Table West USA Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027
-
Table West USA Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027
-
Figure West USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016
-
Figure West USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021
-
Figure West USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027
-
Table West USA Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027
-
Table West USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016
-
Figure West USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021
-
Figure West USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027
-
Table South USA Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027
-
Table South USA Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027
-
Figure South USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016
-
Figure South USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021
-
Figure South USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027
-
Table South USA Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027
-
Table South USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016
-
Figure South USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021
-
Figure South USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027
-
Table Middle West USA Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027
-
Table Middle West USA Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016
-
Figure Middle West USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021
-
Figure Middle West USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027
-
Table Middle West USA Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016
-
Figure Middle West USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021
-
Figure Middle West USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027
-
Table Northeast USA Companion Diagnostic Tests in Oncology Consumption by Types from 2016 to 2027
-
Table Northeast USA Companion Diagnostic Tests in Oncology Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2016
-
Figure Northeast USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2021
-
Figure Northeast USA Companion Diagnostic Tests in Oncology Consumption Share by Types in 2027
-
Table Northeast USA Companion Diagnostic Tests in Oncology Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2016
-
Figure Northeast USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2021
-
Figure Northeast USA Companion Diagnostic Tests in Oncology Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Siemens Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare
-
Figure Sales and Growth Rate Analysis of Siemens Healthcare
-
Figure Revenue and Market Share Analysis of Siemens Healthcare
-
Table Product and Service Introduction of Siemens Healthcare
-
Table Company Profile and Development Status of BioMerieux
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMerieux
-
Figure Sales and Growth Rate Analysis of BioMerieux
-
Figure Revenue and Market Share Analysis of BioMerieux
-
Table Product and Service Introduction of BioMerieux
-
Table Company Profile and Development Status of Genomic Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health
-
Figure Sales and Growth Rate Analysis of Genomic Health
-
Figure Revenue and Market Share Analysis of Genomic Health
-
Table Product and Service Introduction of Genomic Health
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Thermo Fisher
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher
-
Figure Sales and Growth Rate Analysis of Thermo Fisher
-
Figure Revenue and Market Share Analysis of Thermo Fisher
-
Table Product and Service Introduction of Thermo Fisher
-
Table Company Profile and Development Status of Illumina
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina
-
Figure Sales and Growth Rate Analysis of Illumina
-
Figure Revenue and Market Share Analysis of Illumina
-
Table Product and Service Introduction of Illumina
-
Table Company Profile and Development Status of Agilent
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent
-
Figure Sales and Growth Rate Analysis of Agilent
-
Figure Revenue and Market Share Analysis of Agilent
-
Table Product and Service Introduction of Agilent
-
Table Company Profile and Development Status of QIAGEN
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of QIAGEN
-
Figure Sales and Growth Rate Analysis of QIAGEN
-
Figure Revenue and Market Share Analysis of QIAGEN
-
Table Product and Service Introduction of QIAGEN
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Agendia
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agendia
-
Figure Sales and Growth Rate Analysis of Agendia
-
Figure Revenue and Market Share Analysis of Agendia
-
Table Product and Service Introduction of Agendia
-
